Lv1
44 积分 2023-04-11 加入
Discovery of DFV890, a Potent Sulfonimidamide-Containing NLRP3 Inflammasome Inhibitor
14小时前
待确认
Inflammasome components as new therapeutic targets in inflammatory disease
1个月前
已完结
The role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases
1个月前
已完结
Discovery of a Novel Oral Proteasome Inhibitor to Block NLRP3 Inflammasome Activation with Anti-inflammation Activity
2个月前
已完结
Role of NLRP3 Inflammasome in Stroke Pathobiology: Current Therapeutic Avenues and Future Perspective
2个月前
已完结
Discovery of Clinical Candidate NT-0796, a Brain-Penetrant and Highly Potent NLRP3 Inflammasome Inhibitor for Neuroinflammatory Disorders
2个月前
已完结
Parkinson Disease Genetics: A “Continuum” from Mendelian to Multifactorial Inheritance
2个月前
已完结
Neuroinflammation-mediated white matter injury in Parkinson’s disease and potential therapeutic strategies targeting NLRP3 inflammasome
2个月前
已完结
The research progression of direct NLRP3 inhibitors to treat inflammatory disorders
2个月前
已完结
MCC950 as a promising candidate for blocking NLRP3 inflammasome activation: A review of preclinical research and future directions
2个月前
已完结
皖公网安备34019202002308
